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We describe a case of the isolation of Bartonella quintana from the parotid gland of an apparently healthy
man. Pathological examination showed intraparotid granulomatous abscessual lymphadenitis. Diagnosis was
made on the basis of high titers of immunoglobulin G (IgG) and IgM antibodies and of culture isolation of a
causative agent from parotid aspirate.
CASE REPORT
An apparently healthy 58-year-old man presented in April
2001 to the emergency room of our Dipartimento di Scienze
Otorinolaringoiatriche of the University of Palermo with a
swollen, indolent mass in the right retromandibular region that
had appeared 3 days earlier. He did not report other relevant
clinical data and had no cats or other pets at home.
His general condition was satisfactory, and the patient was
apyrexial. Clinical investigation revealed a palpable, not pul-
sating, indolent mass (approximately 3 by 2 cm) behind the
mandibular angle in the region of the right parotid, not adher-
ing with the overlying erythematous skin. The cervical lymph
nodes were enlarged only on the right side. The physical ex-
aminations of the other systems were essentially normal. In
addition, 2 days after admission, the patient reported the ap-
pearance of a little (0.4- by 0.4-cm), painful phlogistic ulcer-
ation on the skin of the right cheek.
For differential diagnosis, we considered infectious causes,
collagen vascular diseases, sarcoidosis, neoplasms, sialolithia-
sis, alcoholism, and congenital masses. Particularly, we consid-
ered viral (i.e., cytomegalovirus, Epstein-Barr virus, and hu-
man immunodeficiency virus infection), bacterial (Brucella),
tuberculosis, and protozoan (Leishmania infantum and Toxo-
plasma gondii) etiology, using both in vivo (i.e., Mantoux test)
and in vitro (i.e., serologic assays) tests and direct examination
of parotid mass aspirate (see below).
Table 1 shows the results of the routine hematochemistry
and serologic assays performed during hospitalization. Ultra-
sonography and computed tomography of the neck showed a
mass (3.5 by 3 cm), attributable to the right parotid gland, with
swelling of the intraparotid lymph nodes. Chest X ray, trans-
thoracic echocardiography, and ultrasonography of the abdo-
men were normal.
Aspirate from the right parotid mass showed an inflamma-
tory infiltration of lymphocytes in different phases of follicular
nodulation together with polymorphonuclear leukocyte and
epithelioid histiocyte populations—pathological findings that
are compatible with the diagnosis of intraparotid granuloma-
tous abscessual lymphadenitis. The approximate relative per-
centages of cells in the parotid aspirate were as follows: lym-
phocytes, 30%; polymorphonuclear leukocytes, 30%; and
epithelioid histiocytes, 40%.
The serum sample was examined by the indirect fluores-
cent antibody test for the presence of immunoglobulin G
(IgG) and IgM class antibodies to Bartonella quintana and
Bartonella henselae. For antigens, we used either our pre-
pared in-house slides or commercial slides (Focus Technol-
ogies, Cypress, California, distributed in Italy by Alifax). We
prepared the in-house slides by using B. henselae strain
Houston-1 and B. quintana strain Oklahoma as antigens,
obtained from the collection of the National Reference
Center of Rickettsiosis, Marseille, France, and grown in
Vero cells for 2 weeks. An IgG titer of 1:64 and IgM titer
of 1:20 were used as cutoffs (18).
The final diagnosis of B. quintana infection was first sug-
gested by the finding of high titers of IgG and IgM antibod-
ies for this agent, 1:256 and 1:40, respectively (serology for
B. henselae was negative), and then was confirmed by the
isolation and characterization of B. quintana from the pa-
rotid aspirate.
In particular, the isolation of B. quintana was performed
on Columbia 5% sheep blood agar plates (BioMerieux,
Marcy-l’Etoile, France). Inoculated plates were incubated at
37°C under 5% CO2 for 30 to 40 days and controlled weekly
for evidence of bacterial growth. Four weeks after some Bartonel-
la-like colonies became visible, and 2 weeks after that, they
were inoculated in a Vero cell monolayer and incubated at
37°C under 5% CO2 for 2 weeks. Then, infected Vero cells
were examined by the indirect fluorescent antibody test, using
human B. henselae and B. quintana hyperimmune serum from
our collection, and B. quintana, the only demonstrated micro-
organism, was characterized by using PCR as previously re-
ported (17). The amplicon size was 619 bp, and the sequence
was 100% identical to that of the B. quintana intergenic tran-
scribed sequence (GenBank accession no. 897700).
Meanwhile, antibiotics (clarithromycin, 500 mg orally
twice a day [b.i.d.], and ceftazidime, 1 g intramuscularly
b.i.d.), together with nonsteroidal anti-inflammatory drugs
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(nimesulide, 100 mg orally three times a day) and steroids
(deflazacort, 6 mg orally b.i.d., and betamethasone, 4 mg
intramuscularly once daily), were administered for 14 days.
The mass completely disappeared within 3 months, and the
6-, 12-, and 24-month and 3-year follow-up visits were com-
pletely normal. Serology for B. quintana, performed at the
6-month follow-up visit, demonstrated an IgG titer of 1:256
and an IgM titer of 1:20. At 24 months, serology for IgM was
negative, whereas serology for IgG was at the cutoff titer
(1:64). After 3 years, serology was repeated, and the results
were negative for both IgM and IgG.
Since its first descriptions during World War I, trench fever
has appeared on every continent except Australia and Antarc-
tica. In Europe and North America, infection with B. quintana
is nowadays associated with poverty, alcoholism, and home-
lessness. Body lice seem to be the principal vector of B. quin-
tana infection, although other ectoparasites, such as mites or
cat fleas, might conceivably play a role in disease transmission
(3, 8, 10, 13, 16). Unlike for most other Bartonella species,
there is currently no clear evidence to support the existence of
an animal reservoir for B. quintana (4, 11, 15).
Descriptions of the clinical manifestations of B. quintana
infection in the immunocompetent host vary tremendously.
Features of “classic” trench fever include fever, sometimes
occurring at 5-day intervals with asymptomatic intervening pe-
riods (so-called quintan fever); debilitating and persistent
typhoidal illness, often lasting many months; transient maculo-
papular rash; conjunctivitis; severe headache; myalgias; and, in
chronic cases, splenomegaly. Progression to death is extremely
rare (12).
B. quintana, together with B. henselae, is also associated with
bacillary angiomatosis, a bacterial infection characterized by
the proliferation of blood vessels, resulting in the appearance
of tumorlike masses in the skin and other organs (liver, spleen,
bone marrow). It most commonly manifests in people affected
by acquired immune deficiency syndrome, rarely appearing in
immunocompetent individuals. While curable, it is potentially
fatal if not treated (5, 9, 19).
The recent descriptions of B. quintana bacteremia in urban
homeless persons also reveal heterogeneous patterns of illness,
especially chronic bacteremia and endocarditis, sometimes
with severe and progressive valvular damage requiring valve
replacement for the cure. These findings suggest that, although
B. quintana clearly may cause acute and severe illness in home-
less persons, it often produces a chronic and nonspecific illness
that does not arouse clinical suspicion for Bartonella infection
(2, 6).
Finally, B. quintana has also been reported to cause isolated
chronic lymphadenopathy in both immunodepressed and im-
munocompetent individuals, with the pathological features of a
granulomatous reaction and without fever and/or other symp-
tom/signs (7).
Confirming B. quintana infection requires serological assays
(including indirect immunofluorescence-based techniques),
specific cultures, and nucleic acid amplification procedures (1).
For therapy, treatment of uncomplicated B. quintana bacte-
remia with a 4- to 6-week course of doxycycline (100 mg orally
b.i.d.), erythromycin (500 mg orally four times a day), or
azithromycin (500 mg orally once daily) is recommended. Pa-
tients with endocarditis should receive 4 to 6 months of ther-
apy, with close monitoring for indications of the need for valve
replacement. Some authorities would recommend the addition
of a bactericidal agent, such as a third-generation cephalospo-
rin or an aminoglycoside, in the initial 2 to 3 weeks of therapy
for treating endocarditis (7, 14).
To our knowledge, this is the first case of B. quintana infec-
tion characterized by parotid gland localization, without fever
or other symptoms/signs suggesting trench fever or other B.
quintana infection features, in an immunocompetent individ-
ual. We think that the phlogistic ulceration on the skin of the
right cheek is the site of the body louse bite, even if the patient
did not report anything about it. In addition, the pathological
examination of the mass showed an intraparotid granuloma-
TABLE 1. Laboratory findings
Laboratory testing Result Normal range or result
Red blood cell count 5,440,000 cells/l 4,000,000–6,000,000
cells/l
Hemoglobin 15.2 g/dl 12–17 g/dl
Hematocrit 46.3% 40.7–50.3%
Mean corpuscular volume 83.6 m3 80–99 m3
Mean corpuscular hemoglobin 27.4 pg/cell 26–38 pg/cell
Platelet count 319,000 cells/l 150,000–450,000
cells/l
White blood cell count 9,470 cells/l 5,000–9,000 cells/l
Differential leukocyte count
Neutrophils 57.4%
Lymphocytes 27.6%
Monocytes 9.0%
Eosinophils 5.5%
Prothrombin activity 100% 70–120%
International normalized ratio 1.18 0.90–1.20
Activated partial
thromboplastin time
31.0 s 18–35 s
Serum fibrinogen 450 mg/dl 200–400 mg/dl
Glycemia 98.0 mg/dl 70–105 mg/dl
Serum urea nitrogen 23.0 mg/dl 10–50 mg/dl
Serum creatinine 1.22 mg/dl 0.60–1.20 mg/dl
Serum sodium 140 meq/liter 136–146 meq/liter
Serum potassium 4.90 meq/liter 3.50–5.10 meq/liter
Total serum protein 6.8 g/liter 6.6–8.3 g/liter
Serum protein fractions
Albumin 3.09 g/dl 3.48–5.39 g/dl
1-Globulin 0.25 g/dl 0.20–0.50 g/dl
2-Globulin 0.84 g/dl 0.45–0.97 g/dl
1-Globulin 0.63 g/dl 0.32–0.51 g/dl
2-Globulin 0.29 g/dl 0.20–0.53 g/dl
Gamma globulin 1.00 g/dl 0.67–1.56 g/dl
Aspartate transaminase 22 units/liter 40 units/liter
Alanine transaminase 12 units/liter 40 units/liter
Pseudocholinesterase 8,890 units/liter 5,400–13,200 units/liter
Total bilirubin 0.50 mg/dl 1.0 mg/dl
Direct bilirubin 0.15 mg/dl 0.25 mg/dl
Erythrocyte sedimentation rate 15 mm/h 14 mm/h
Urinary analysis Normal Normal
Cytomegalovirus serology test Negative Negative
Epstein-Barr virus serology test Negative Negative
Hepatitis B virus serology test Negative Negative
Hepatitis C virus serology test Negative Negative
Human immunodeficiency virus
serology test
Negative Negative
Brucella serology test Negative Negative
Mantoux test Negative Negative
Mycobacterium tuberculosis
serology test
Negative Negative
Leishmania infantum
serology test
Negative Negative
Direct examination of parotid
mass aspirate
Negative Negative
Toxoplasma gondii serology test Negative Negative
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tous abscessual lymphadenitis more characteristic of B.
henselae infection, i.e., cat scratch disease, than of B. quintana
infection. It is thus possible to hypothesize a different specific
B. quintana strain infection and/or different genetic character-
istics for our patient, which is not easily demonstrated. With
this subject, diagnosis was made on the basis of physical exam-
ination, high titers of the IgG and IgM antibodies against this
agent, and especially, culture isolation from the mass. Therapy
was successfully conducted by following the guidelines for
complicated cases of B. quintana infection, i.e., endocarditis,
with antibiotic association (macrolides plus cephalosporins)
(7, 14).
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